<div dir="ltr">Hi Jason,<div><br></div><div class="gmail_extra"><div class="gmail_quote"><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex"><div style="word-wrap:break-word"><div style="margin:0px;line-height:normal"><div style="margin:0px;font-size:8px;line-height:normal"><br>
</div>
</div>
<div>The ligand and APHE got pushed away from one another and off of their respective densities. Occupancies for both were reduced to 0.5 for the refinement. What am I doing wrong here? Does the ligand need to have an altloc as well? But I don’t see
an alternative conformation. </div></div></blockquote><div><br></div><div>Yes, the ligand also needs an altloc, and it should be different from PHE altloc. This way the refinement will know that these atoms don't see each other. You don't have to put two alternative conformations for the ligand, you can have just one with partial occupancy (<1.0) which will mean that the ligand is not always there.</div><div> </div><div>Best regards,</div><div>Oleg Sobolev.</div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div style="word-wrap:break-word">
<br>
<div>
<blockquote type="cite">
<div>On Feb 28, 2018, at 5:35 PM, van den Bedem, Henry <<a href="mailto:vdbedem@slac.stanford.edu" target="_blank">vdbedem@slac.stanford.edu</a>> wrote:</div>
<br class="m_8858005827093028639Apple-interchange-newline">
<div>
<div class="m_8858005827093028639WordSection1" style="font-family:Helvetica;font-size:14px;font-style:normal;font-variant-caps:normal;font-weight:normal;letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px">
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
If the phe is a gatekeeper, shouldn’t the ligand be refined at partial occupancy; i.e. occupancies not necessarily have to ‘add up’ as you suggest? Maybe this link is helpful too:<span class="m_8858005827093028639Apple-converted-space"> </span><a href="http://www.biorxiv.org/content/early/2018/01/24/253419" style="color:rgb(149,79,114);text-decoration:underline" target="_blank">www.biorxiv.org/content/<wbr>early/2018/01/24/253419</a><u></u><u></u></div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<u></u> <u></u></div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
H<u></u><u></u></div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<u></u> <u></u></div>
<div style="border-style:solid none none;border-top-width:1pt;border-top-color:rgb(181,196,223);padding:3pt 0in 0in">
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<b><span style="font-size:12pt">From:<span class="m_8858005827093028639Apple-converted-space"> </span></span></b><span style="font-size:12pt"><<a href="mailto:phenixbb-bounces@phenix-online.org" style="color:rgb(149,79,114);text-decoration:underline" target="_blank">phenixbb-bounces@<wbr>phenix-online.org</a>>
on behalf of "Phan, Jason" <<a href="mailto:jason.phan@vanderbilt.edu" style="color:rgb(149,79,114);text-decoration:underline" target="_blank">jason.phan@vanderbilt.edu</a>><br>
<b>Date:<span class="m_8858005827093028639Apple-converted-space"> </span></b>Wednesday, February 28, 2018 at 1:30 PM<br>
<b>To:<span class="m_8858005827093028639Apple-converted-space"> </span></b>"<a href="mailto:phenixbb@phenix-online.org" style="color:rgb(149,79,114);text-decoration:underline" target="_blank">phenixbb@phenix-online.<wbr>org</a>" <<a href="mailto:phenixbb@phenix-online.org" style="color:rgb(149,79,114);text-decoration:underline" target="_blank">phenixbb@phenix-online.org</a>><br>
<b>Subject:<span class="m_8858005827093028639Apple-converted-space"> </span></b>[phenixbb] Overlapping ligand-protein side chain density<u></u><u></u></span></div>
</div><span class="">
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<u></u> <u></u></div>
</div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<a name="m_8858005827093028639__MailOriginalBody">All, <span class="m_8858005827093028639Apple-converted-space"> </span><u></u><u></u></a></div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><u></u> <u></u></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>A piece of a ligand and the side chain of a “gate-keeper” Phe occupy the same space with well-defined features observed for both (resolution is 1.7 A). It looks about 50:50. How do you refine both ligand and protein side chain in this case? A
couple of phenixbb suggestions for dealing with ligand-ligand overlapping density have been considered. With the first suggestion, the two entities still clashed and moved apart off of their respective densities. The second suggestion is not applicable in
this case since the other molecule is not a ligand but part of the protein but it was tested anyway. Although there was no bumping, the occupancies don’t add up, resulting in a big blob of negative density around the ligand piece. <u></u><u></u></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><u></u> <u></u></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>------------------------------<u></u><u></u></span></div>
</div>
<div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>Only two comments:<u></u><u></u></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span> <u></u><u></u></span></div>
</div>
<ol start="1" type="a" style="margin-bottom:0in;margin-top:0in">
<li class="MsoNormal" style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>At that resolution, constrained group occupancy refinement should work reasonably well (provided you can model the 2 entities). Then you also do not have clashes between the molecules, because Occ(A)+Occ(B)=1, meaning when one (A) is there, the
other one (B) is not. This works with refmac (external keyword file); if you need more sophisticated occupancy re/constraints SHELXL may offer more opportunities.<u></u><u></u></span></li><li class="MsoNormal" style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>There is no necessity for the two NCS copies of the binding site to look exactly the same (non-equivalent). Maybe there is a good reason/story (accessibility, contacts etc) for one site to be occupied differently than the other one. <u></u><u></u></span></li></ol>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span> <u></u><u></u></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>Best, BR<u></u><u></u></span></div>
</div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span>——————————————<u></u><u></u></span></div>
</div>
<div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica">Modeling two molecules that occupy overlapping binding sites in a structure simply involves designating them as alternate conformers, with the same chain and residue number, and
an occupancy that sums to 1.0. For example, if you have an AMP and an ADP that occupy the same binding site, you would define them as<u></u><u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica"><u></u> <u></u></span></span></div>
</div>
<div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Courier">AAMP B 501</span></span><span><span style="font-size:10.5pt;font-family:Helvetica"><u></u><u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Courier">BADP B 501</span></span><span><span style="font-size:10.5pt;font-family:Helvetica"><u></u><u></u></span></span></div>
</div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica"><u></u> <u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica">and initially set the occupancies for the atoms in each conformer to the ratio (50:50, 30:70, etc.) that you observe in the density.<u></u><u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica"><u></u> <u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica">Refinement in this manner is straightforward in PHENIX.<u></u><u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica"><u></u> <u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica">Diana<u></u><u></u></span></span></div>
</div>
<div>
<div style="margin:0in 0in 0.0001pt;font-size:11pt;font-family:Calibri,sans-serif">
<span><span style="font-size:10.5pt;font-family:Helvetica">----------------------------</span></span></div>
</div>
</div>
</span></div>
</div>
</blockquote>
</div>
<br>
</div>
<br>______________________________<wbr>_________________<br>
phenixbb mailing list<br>
<a href="mailto:phenixbb@phenix-online.org">phenixbb@phenix-online.org</a><br>
<a href="http://phenix-online.org/mailman/listinfo/phenixbb" rel="noreferrer" target="_blank">http://phenix-online.org/<wbr>mailman/listinfo/phenixbb</a><br>
Unsubscribe: <a href="mailto:phenixbb-leave@phenix-online.org">phenixbb-leave@phenix-online.<wbr>org</a><br></blockquote></div><br></div></div>